{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:42:02Z","timestamp":1773146522269,"version":"3.50.1"},"reference-count":38,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2007,6,11]],"date-time":"2007-06-11T00:00:00Z","timestamp":1181520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Head &amp; Neck"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The current study aimed to evaluate the significance of the cell\u2010cycle\u2010control proteins cyclin D1 and p16 as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with docetaxel and radiotherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Cyclin D1 and\/or p16 protein expression was retrospectively evaluated by immunohistochemistry in 53 patients with stage T1\u20103N0\u20102M0 (except T1N0 glottis) HNSCC who were treated with 10 mg\/m<jats:sup>2<\/jats:sup>\/week docetaxel 4 to 6 times and received concurrent chemoradiotherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Kaplan\u2013Meier univariate analysis revealed that patients with cyclin D1\u2010positive tumors or p16\u2010negative tumors had a worse prognosis compared with those with cyclin D1\u2010negative tumors or p16\u2010positive tumors (<jats:italic>p<\/jats:italic> = .0004 and <jats:italic>p<\/jats:italic> = .025, respectively). The prognostic significance of cyclin D1 expression, not p16 expression, was confirmed using a proportional hazard regression model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>An assessment of cyclin D1 and p16 levels might be of clinical use in defining subgroups of patients with poor prognosis. \u00a9 2007 Wiley Periodicals, Inc. Head Neck 2007<\/jats:p><\/jats:sec>","DOI":"10.1002\/hed.20632","type":"journal-article","created":{"date-parts":[[2007,6,12]],"date-time":"2007-06-12T04:51:47Z","timestamp":1181623907000},"page":"940-947","source":"Crossref","is-referenced-by-count":26,"title":["Prognostic significance of cyclin D1 and p16 in patients with intermediate\u2010risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy"],"prefix":"10.1002","volume":"29","author":[{"given":"Eisaku","family":"Higuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Oridate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Homma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Atago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsumi","family":"Nagahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,6,11]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<18::AID-IJC5>3.0.CO;2-M"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra001375"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)90011-4"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/83.4.288"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00107a017"},{"key":"e_1_2_6_7_2","first-page":"97","article-title":"Docetaxel and radiation as combined\u2010modality therapy","volume":"16","author":"Kim ES","year":"2002","journal-title":"Oncology"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.cco.0000158735.91723.0e"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-003-0375-z"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(03)01370-1"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2003.11.017"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960301)77:5<834::AID-CNCR5>3.0.CO;2-E"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(05)80109-6"},{"key":"e_1_2_6_14_2","first-page":"801","article-title":"Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy","volume":"5","author":"Homma A","year":"1999","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_15_2","first-page":"3689","article-title":"The Pezcoller lecture: cancer cell cycles revisited","volume":"60","author":"Sherr CJ","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_6_16_2","first-page":"175","article-title":"Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications","volume":"2","author":"Bellacosa A","year":"1996","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.125.9.949"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(97)00198-6"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970115)79:2<380::AID-CNCR22>3.0.CO;2-W"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1179\/joc.1997.9.2.113"},{"key":"e_1_2_6_21_2","first-page":"2810","article-title":"Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue","volume":"5","author":"Bova RJ","year":"1999","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/375503a0"},{"key":"e_1_2_6_23_2","first-page":"6006","article-title":"Immunohistochemical detection of the cyclin\u2010dependent kinase inhibitor 2\/multiple tumor suppressor gene 1 (CDKN2\/MTS1) product p16INK4a in archival human solid tumors: correlation with retinoblastoma protein expression","volume":"55","author":"Geradts J","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(99)90217-4"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1368-8375(98)00024-4"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201309"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/00016489950181837"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20042"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-82982-6_2"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1323"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/35078107"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.4.3.1504"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.4.373"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.31.22013"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.1014"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1080\/028418601750288244"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1080\/00016480410017323"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00130404-200409000-00010"},{"key":"e_1_2_6_39_2","first-page":"59","article-title":"Prognostic significance of cytoplasmic macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy","volume":"13","author":"Suzuki F","year":"2005","journal-title":"Oncol Rep"}],"container-title":["Head &amp; Neck"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhed.20632","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hed.20632","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T04:14:45Z","timestamp":1697602485000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hed.20632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,11]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1002\/hed.20632"],"URL":"https:\/\/doi.org\/10.1002\/hed.20632","archive":["Portico"],"relation":{},"ISSN":["1043-3074","1097-0347"],"issn-type":[{"value":"1043-3074","type":"print"},{"value":"1097-0347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,11]]}}}